INFORMATION BY CANCER TYPE

Leukemia

Vyxeos Helps More Patients With AML Proceed to Transplant
BY Silas Inman
More people with AML who were treated with Vyxeos were moved to transplant than those treated with a standard chemotherapy regimen, according to recent findings.
Inotuzumab Ozogamicin Gets Priority Review for Acute Lymphoblastic Leukemia
BY Silas Inman
Inotuzumab ozogamicin was granted a priority review designation for patients with relapsed or refractory ALL. 
Blincyto Seeks FDA Approval for Leukemia Treatment
BY Jason M. Broderick
A supplemental biologics license application was filed for Blincyto to be approved for certain patients with ALL.
The Need for Targeted Clinical Trials in ALL
BY Lisa Miller
There is a need for more targeted clinical trials for patients with ALL, since many of them have Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia. 
Reaping the Benefits: Exercise Programs Offer Physical and Social Benefits for Cancer Survivors
BY Brielle Urciuoli
Group exercise programs are beneficial to survivors of cancer, and can offer motivation from peers to continue living a healthy lifestyle.
Pivotal Trial Finds That Imbruvica Shows Benefit in CLL and SLL
BY Danielle Bucco
Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.
Cancer Clinical Trials May Benefit Patients Who Typically Don't Qualify
BY Ellie Leick
Many patients with cancer do not qualify for clinical trials because of comorbidities or other health problems. However, a recent study found that many of these patients can actually benefit from trials.
FDA Stops Multiple Trials for Acute Myeloid Leukemia Drug
BY Jason M. Broderick
Several trials testing vadastuximab talirine for use in patients with AML were recently halted, according to the drug's manufacturer.
Safety Data for TKI Cessation Emerges for Chronic Myeloid Leukemia
BY Silas Inman
Recent studies found that for certain patients with CML, it is possible to safely reduce or stop TKI treatment.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Leukemia CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.
Adult Acute Myeloid Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood acute lymphoblastic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Myelogenous Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
Hairy Cell Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of hairy cell leukemia.